These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13804)

  • 21. Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect.
    d'Hollander AA; Duvaldestin P; Henzel D; Delcroix C; Desmonts JM
    Br J Anaesth; 1981 Aug; 53(8):853-8. PubMed ID: 6115662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate of recovery from fazadinium: relationship to the rate of decline of its plasma concentration.
    Ramzan IM
    J Pharm Sci; 1983 Nov; 72(11):1369-70. PubMed ID: 6139474
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxogonin: blood levels and side effects after intramuscular administration in man.
    Sidell FR; Groff WA
    J Pharm Sci; 1970 Jun; 59(6):793-7. PubMed ID: 5423080
    [No Abstract]   [Full Text] [Related]  

  • 25. Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.
    d'Hollander AA; Delcroix C; Duvaldestin P; Henzel D; Coussaert E; Desmonts JM
    Eur J Clin Pharmacol; 1983; 24(3):407-13. PubMed ID: 6134623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New muscle relaxants: effect on intracranial pressure and on cerebral perfusion pressure].
    Rosa G; Di Giugno G; Orfei P
    Minerva Anestesiol; 1987 May; 53(5):315-20. PubMed ID: 2893997
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics of fazadinium in man.
    Duvaldestin P; Henzel D; Demetriou M; Desmonts JM
    Br J Anaesth; 1978 Aug; 50(8):773-7. PubMed ID: 28133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between pharmacokinetics and pharmacodynamics of fazadinium in rabbits.
    Dominguez-Gil AA; Cepeda M; Muriel C; Calvo JI; Dominguez-Gil A; Alonso AC
    Arzneimittelforschung; 1981; 31(11):1913-7. PubMed ID: 6119095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in intracranial pressure during muscle relaxation with fazadinium bromide].
    Stella L; Falivene R; Gargiulo G; Mastronardi P; Cafiero T; De Santis L
    Minerva Anestesiol; 1984 Apr; 50(4):123-5. PubMed ID: 6147795
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical comparison of AH8165 and pancuronium as muscle relaxants in patients undergoing cardiac surgery.
    Lyons SM; Clarke RS; Young HS
    Br J Anaesth; 1975 Jun; 47(6):725-9. PubMed ID: 238553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of adrenergic cardiovascular effects of two quaternary nicotine analogues by reserpine.
    von Euler US; Persson NA
    Acta Physiol Scand; 1970 Apr; 78(4):459-64. PubMed ID: 5449085
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fazadinium and presynaptic effects].
    González Miranda F; Pascual del Riquelme y Viudes R
    Rev Esp Anestesiol Reanim; 1987; 34(5):396-8. PubMed ID: 2891159
    [No Abstract]   [Full Text] [Related]  

  • 33. AH 8165: a new short-acting, competitive neuromuscular blocking drug.
    Brittain RT; Tyers MB
    Br J Pharmacol; 1972 May; 45(1):158P-159P. PubMed ID: 4625270
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in plasma potassium and sodium following fazadinium bromide.
    Famewo CE; Fajimi JL
    Anaesthesia; 1981 Feb; 36(2):226-7. PubMed ID: 6111263
    [No Abstract]   [Full Text] [Related]  

  • 35. [The influence of AH8165, a new non-depolarizing muscle relaxant on the haemodynamics in man (author's transl)].
    Patschke D; Brückner JB; Tarnow J; Weymar A
    Anaesthesist; 1974 Oct; 23(10):430-3. PubMed ID: 4156627
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
    Camu F; Sanders M; D'Hollander A
    Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological evaluation of imidazopyridinium derivatives as neuromuscular blocking agents.
    Bellani P; Clavenna G; Sosio A
    Farmaco Sci; 1984 Oct; 39(10):846-62. PubMed ID: 6510519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacology of fazadinium (AH 8165)].
    Kienlen J; du Callar J
    Ann Anesthesiol Fr; 1981; 22(6):631-9. PubMed ID: 6124193
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of bis-pyridinium oximes on neuromuscular blockade induced by highly toxic organophosphates in rat.
    Jovanović D
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):231-41. PubMed ID: 6307195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.